Skip to main navigation

Newsroom
Get in Touch
LinkedIn

Research and Pipeline
CRISPR Gene Editing
For Patients
Who We Are
Join Our Team
Investors

Newsroom
Get in Touch
LinkedIn

Media & Investors

Overview
Press Releases
Events & Presentations
Corporate Governance
Financials & Filings
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
Investor FAQs
Contact

Contact

Contact

For Investors and Media:

Editas Medicine, Inc.
E-mail: ir@editasmed.com

>> Main navigation

Research and Pipeline
CRISPR Gene Editing
For Patients
Who We Are
Join Our Team
Investors

©Copyright 2024 Editas Medicine

>> Footer menu

Get in Touch
Investors
Privacy Policy
Terms of Use